Literature DB >> 28120850

Critical role of CXCL4 in the lung pathogenesis of influenza (H1N1) respiratory infection.

L Guo1, K Feng1, Y C Wang1, J J Mei1,2, R T Ning1, H W Zheng1, J J Wang1, G S Worthen2, X Wang1, J Song1, Q H Li1, L D Liu1.   

Abstract

Annual epidemics and unexpected pandemics of influenza are threats to human health. Lung immune and inflammatory responses, such as those induced by respiratory infection influenza virus, determine the outcome of pulmonary pathogenesis. Platelet-derived chemokine (C-X-C motif) ligand 4 (CXCL4) has an immunoregulatory role in inflammatory diseases. Here we show that CXCL4 is associated with pulmonary influenza infection and has a critical role in protecting mice from fatal H1N1 virus respiratory infection. CXCL4 knockout resulted in diminished viral clearance from the lung and decreased lung inflammation during early infection but more severe lung pathology relative to wild-type mice during late infection. Additionally, CXCL4 deficiency decreased leukocyte accumulation in the infected lung with markedly decreased neutrophil infiltration into the lung during early infection and extensive leukocyte, especially lymphocyte accumulation at the late infection stage. Loss of CXCL4 did not affect the activation of adaptive immune T and B lymphocytes during the late stage of lung infection. Further study revealed that CXCL4 deficiency inhibited neutrophil recruitment to the infected mouse lung. Thus the above results identify CXCL4 as a vital immunoregulatory chemokine essential for protecting mice against influenza A virus infection, especially as it affects the development of lung injury and neutrophil mobilization to the inflamed lung.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28120850     DOI: 10.1038/mi.2017.1

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  36 in total

Review 1.  Molecular pathways of platelet factor 4/CXCL4 signaling.

Authors:  Brigitte Kasper; Frank Petersen
Journal:  Eur J Cell Biol       Date:  2011-02-03       Impact factor: 4.492

Review 2.  CXCR3 ligands in disease and therapy.

Authors:  Katrien Van Raemdonck; Philippe E Van den Steen; Sandra Liekens; Jo Van Damme; Sofie Struyf
Journal:  Cytokine Growth Factor Rev       Date:  2014-11-22       Impact factor: 7.638

3.  Disruption of platelet-derived chemokine heteromers prevents neutrophil extravasation in acute lung injury.

Authors:  Jochen Grommes; Jean-Eric Alard; Maik Drechsler; Sarawuth Wantha; Matthias Mörgelin; Wolfgang M Kuebler; Michael Jacobs; Philipp von Hundelshausen; Philipp Markart; Malgorzata Wygrecka; Klaus T Preissner; Tilman M Hackeng; Rory R Koenen; Christian Weber; Oliver Soehnlein
Journal:  Am J Respir Crit Care Med       Date:  2012-01-12       Impact factor: 21.405

4.  The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages.

Authors:  B Scheuerer; M Ernst; I Dürrbaum-Landmann; J Fleischer; E Grage-Griebenow; E Brandt; H D Flad; F Petersen
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

5.  Platelet factor 4 induces human natural killer cells to synthesize and release interleukin-8.

Authors:  Francesc Martí; Esther Bertran; Montserrat Llucià; Esther Villén; Matilde Peiró; Joan Garcia; Fèlix Rueda
Journal:  J Leukoc Biol       Date:  2002-09       Impact factor: 4.962

6.  Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.

Authors:  Mark D Wareing; Ashley B Lyon; Bao Lu; Craig Gerard; Sally R Sarawar
Journal:  J Leukoc Biol       Date:  2004-07-07       Impact factor: 4.962

7.  Platelet factor 4 mediates inflammation in experimental cerebral malaria.

Authors:  Kalyan Srivastava; Ian A Cockburn; AnneMarie Swaim; Laura E Thompson; Abhai Tripathi; Craig A Fletcher; Erin M Shirk; Henry Sun; M Anna Kowalska; Karen Fox-Talbot; David Sullivan; Fidel Zavala; Craig N Morrell
Journal:  Cell Host Microbe       Date:  2008-08-14       Impact factor: 21.023

8.  Human neutrophil defensins increase neutrophil uptake of influenza A virus and bacteria and modify virus-induced respiratory burst responses.

Authors:  Tesfaldet Tecle; Mitchell R White; Don Gantz; Erika C Crouch; Kevan L Hartshorn
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

9.  Platelet factor 4 differentially modulates CD4+CD25+ (regulatory) versus CD4+CD25- (nonregulatory) T cells.

Authors:  Chao Yan Liu; Manuela Battaglia; Seon Ho Lee; Qi-Hong Sun; Richard H Aster; Gian Paolo Visentin
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

10.  CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3.

Authors:  Anja Mueller; Andrea Meiser; Ellen M McDonagh; James M Fox; Sarah J Petit; Georgina Xanthou; Timothy J Williams; James E Pease
Journal:  J Leukoc Biol       Date:  2008-01-03       Impact factor: 4.962

View more
  28 in total

1.  Chemokine PF4 Inhibits EV71 and CA16 Infections at the Entry Stage.

Authors:  Zhichao Pei; Hong Wang; Zhilei Zhao; Xiang Chen; Chen Huan; Wenyan Zhang
Journal:  J Virol       Date:  2022-05-17       Impact factor: 6.549

2.  Identification of a nerve-associated, lung-resident interstitial macrophage subset with distinct localization and immunoregulatory properties.

Authors:  Basak B Ural; Stephen T Yeung; Payal Damani-Yokota; Joseph C Devlin; Maren de Vries; Paola Vera-Licona; Tasleem Samji; Catherine M Sawai; Geunhyo Jang; Oriana A Perez; Quynh Pham; Leigh Maher; P'ng Loke; Meike Dittmann; Boris Reizis; Kamal M Khanna
Journal:  Sci Immunol       Date:  2020-03-27

Review 3.  Platelets in Viral Infections - Brave Soldiers or Trojan Horses.

Authors:  Waltraud C Schrottmaier; Anna Schmuckenschlager; Anita Pirabe; Alice Assinger
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

4.  Haem oxygenase protects against thrombocytopaenia and malaria-associated lung injury.

Authors:  Isaclaudia G de Azevedo-Quintanilha; Isabel M Medeiros-de-Moraes; André C Ferreira; Patrícia A Reis; Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Patricia T Bozza; Guy A Zimmerman; Hugo C Castro-Faria-Neto
Journal:  Malar J       Date:  2020-07-01       Impact factor: 2.979

Review 5.  Role of Platelets in Detection and Regulation of Infection.

Authors:  Irina Portier; Robert A Campbell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-29       Impact factor: 8.311

Review 6.  Targeting SARS-CoV-2-Platelet Interactions in COVID-19 and Vaccine-Related Thrombosis.

Authors:  Dermot Cox
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

7.  Brief report: Circulating markers of fibrosis are associated with immune reconstitution status in HIV-infected men.

Authors:  F A Tobolowsky; N Wada; O Martinez-Maza; L Magpantay; S L Koletar; F J Palella; T T Brown; J E Lake
Journal:  PLoS One       Date:  2018-01-30       Impact factor: 3.240

Review 8.  Platelets in Immune Response to Virus and Immunopathology of Viral Infections.

Authors:  Eugenio D Hottz; Fernando A Bozza; Patrícia T Bozza
Journal:  Front Med (Lausanne)       Date:  2018-04-30

Review 9.  Animal models of mechanisms of SARS-CoV-2 infection and COVID-19 pathology.

Authors:  Simon J Cleary; Simon C Pitchford; Richard T Amison; Robert Carrington; C Lorena Robaina Cabrera; Mélia Magnen; Mark R Looney; Elaine Gray; Clive P Page
Journal:  Br J Pharmacol       Date:  2020-07-19       Impact factor: 8.739

10.  CXCL4 contributes to host defense against acute Pseudomonas aeruginosa lung infection.

Authors:  Lei Yue; Zheng Pang; Hua Li; Ting Yang; Lei Guo; Longding Liu; Junjie Mei; Xia Song; Tianhong Xie; Ye Zhang; Xin He; Tong-Jun Lin; Zhongping Xie
Journal:  PLoS One       Date:  2018-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.